Results 81 to 90 of about 1,041,807 (313)

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Implanted Standby Defibrillators [PDF]

Circulation, 1973
M, Mirowski, M M, Mower, A I, Mendeloff
openaire   +5 more sources

Electromagnetic Interference in Patients with Implanted Cardioverter-Defibrillators and Implantable Loop Recorders

Indian Pacing and Electrophysiology Journal, 2002
Modern life exposes us all to an ever-increasing number of potential sources of electromagnetic interference (EMI) and patients with Implantable rhythm devices (IRD) like pacemakers, implantable cardioverter defibrillators or implantable loop recorders ...
Marcos de Sousa, Gunnar Klein, Thomas Korte, Michael Niehaus   +3 more
doaj  

Management of Radiotherapy Patients with Implanted Cardiac Pacemakers and Defibrillators: A Report of the AAPM TG-203.

Medical Physics (Lancaster), 2019
Managing radiotherapy patients with implanted cardiac devices (Implantable Cardiac Pacemakers and Implantable Cardioverter-defibrillators) has been a great practical and procedural challenge in radiation oncology practice.
M. Miften, D. Mihailidis, S. Kry, C. Reft, C. Esquivel, J. Farr, D. Followill, C. Hurkmans, Arthur K Liu, O. Gayou, M. Gossman, M. Mahesh, R. Popple, J. Prisciandaro, J. Wilkinson   +14 more
semanticscholar   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Subcutaneous Implantable Cardioverter Defibrillator [PDF]

Circulation: Arrhythmia and Electrophysiology, 2012
Implantable cardioverter-defibrillators (ICDs) represent a very effective therapy for primary and secondary prevention of sudden cardiac death (SCD). However, implantation of endocardial leads using a transvenous approach is associated with significant procedural and long term complications.
Christopher P, Rowley, Michael R, Gold
openaire   +2 more sources

The death of cost-minimization analysis? [PDF]

, 2001
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Altman, Briggs, Connolly, Connolly, Donaldson, Drummond, Drummond, Freiman, Gold, Kuck, Laska, O'Brien, O'Brien, Robinson, Robinson, Robinson, Robinson, Senn, Stinnett, Stinnett, Tambour, van Hout   +21 more
core   +2 more sources

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy [PDF]

, 2005
Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular
Francis, Johnson, Ghosh, Joydeep, Maron, Barry J.   +2 more
core   +1 more source

Inappropriate implantable cardioverter defibrillator shocks—incidence, effect, and implications for driver licensing [PDF]

, 2017
PurposePatients with implantable cardioverter defibrillators (ICDs) have an ongoing risk of sudden incapacitation that may cause traffic accidents. However, there are limited data on the magnitude of this risk after inappropriate ICD therapies.
Abe Haruhiko, Aizawa Yoshifusa, Asai Toru, Fujii Eitaro, Honda Toshihiro, Kasai Atsunobu, Kiyono Ken, Kohno Ritsuko, Kurita Takashi, Manaka Tetsuyuki, Morishima Itsuro, Nitta Takashi, Noda Takashi, Ohmori Hiroya, Okajima Katsunori, Okumura Ken, Ozawa Tomoya, Shimane Akira, Takagi Masahiko, Watanabe Eiichi, Watanabe Shigeyuki, Yamashiro Kohei, 渡邉 重行   +22 more
core   +2 more sources